Bristol gains approval of first-in-class immunotherapy for melanoma Opdualag

0
image_1077050386.jpg

Bristol gains approval of first-in-class immunotherapy for melanoma Opdualag

Source link

More Stories

f14fdbf0-b9b3-11ec-bfbd-980f9d40cd19.jpeg

Berkshire loves its oil stocks, but Goldman thinks another one is a better buy

0
og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png

Global stock markets down in anticipation of the U.S. rate hike

0
2335513d-4844-4424-ba8d-21b65959ce69.jpg

European stocks slide after gloomy data add to global economic worries

0

Leave a Reply

Your email address will not be published. Required fields are marked *

You may have missed

3164088.jpg

RichTech posts RM6mil net profit in FY24 ahead of ACE Market debut

0
UTHR-insidermonkey-1695836190069.jpg

United Therapeutics Corporation (UTHR): A Cheap Biotech Stock to Invest In Now

0
4def54b8-2c2b-4a78-a84a-48aa00d2f916.jpg

FSB warns of risks posed by hedge funds’ ‘hidden leverage’

0
250544.png

Tropical storm set to bring heavy rain to wide areas of Japan

0
refinery-2251247_1920.jpg

12 States With The Largest Refining Capacity

0